Patents Assigned to Veracyte, Inc.
  • Patent number: 11976329
    Abstract: The present disclosure provides systems, methods, and classifiers for differentiating between samples as usual interstitial pneumonia (UIP) or non-UIP.
    Type: Grant
    Filed: December 21, 2021
    Date of Patent: May 7, 2024
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Jing Huang, Yoonha Choi, Daniel Pankratz, Patric Sean Walsh
  • Patent number: 11639527
    Abstract: The present invention provides methods for sequencing and analysis of nucleic acids and determining that a subject is positive for a non-usual interstitial pneumonia subtype.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: May 2, 2023
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, James Diggans, Jing Huang, Yoonha Choi, Su Yeon Kim, Daniel Pankratz, Moraima Pagan
  • Patent number: 11217329
    Abstract: The methods disclosed herein can be used to determine sample integrity, such as sample identity, by using kinship coefficients. Kinship coefficients between two samples can be determined by measuring genetic relatedness in order to determine whether the samples are related or not related.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: January 4, 2022
    Assignee: Veracyte, Inc.
    Inventors: Yoonha Choi, Joshua Babiarz, Giulia C. Kennedy, Jing Huang
  • Patent number: 10934587
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: March 2, 2021
    Assignee: Veracyte, Inc.
    Inventors: Giulia Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 10731223
    Abstract: The present invention relates to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer, including but not limited to gene expression product markers associated with cancer or genetic disorders. In particular, the present invention provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: August 4, 2020
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde
  • Patent number: 10672504
    Abstract: The present invention relates to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer, including but not limited to gene expression product markers associated with cancer or genetic disorders. In particular, the present invention provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: June 2, 2020
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde, Bonnie H. Anderson, Hui Wang, Moraima Pagan, Nusrat Rabbee
  • Patent number: 10526655
    Abstract: The invention in some aspects provides methods of determining the likelihood that a subject has COPD based on the expression of informative-genes. In other aspects, the invention provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the invention.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 7, 2020
    Assignee: Veracyte, Inc.
    Inventors: Duncan H. Whitney, Jun Luo
  • Patent number: 10446272
    Abstract: Disclosed herein are kits, compositions, and methods relating to the classification of samples. Methods disclosed herein can be used to identify sample mix-ups. Methods disclosed herein can also be used to diagnose conditions or to support treatment-related decisions.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: October 15, 2019
    Assignee: Veracyte, Inc.
    Inventors: Jonathan I. Wilde, Darya Chudova, Giulia C. Kennedy
  • Patent number: 10236078
    Abstract: The present disclosure provides methods for processing or analyzing a sample of tissue of a subject, to generate a classification of the sample of tissue as positive or negative for thyroid cancer. The present disclosure also provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: March 19, 2019
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde
  • Patent number: 10114924
    Abstract: The present disorders disclosure provides method for processing or analyzing a sample of thyroid tissue of a subject, to generate a classification of the sample of thyroid tissue as positive or negative for thyroid cancer. The present disclosure also provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results, which may be used to provide a diagnosis.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: October 30, 2018
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde, Bonnie H. Anderson, Hui Wang, Moraima Pagan, Nusrat Rabbee
  • Patent number: 9495515
    Abstract: The present invention relates to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer, including but not limited to gene expression product markers associated with cancer or genetic disorders. In particular, the present invention provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: November 15, 2016
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde
  • Publication number: 20140378425
    Abstract: The present disclosure provides methods for diagnosis of interstitial lung diseases (ILDs). The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from other ILDs. Compositions and kits useful in carrying out a subject method are also provided.
    Type: Application
    Filed: March 14, 2014
    Publication date: December 25, 2014
    Applicant: Veracyte, Inc.
    Inventors: Jonathan I. Wilde, Sharlene Velichko, Catalin Barbacioru, James Diggans, Giulia Kennedy
  • Publication number: 20140349864
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: November 21, 2013
    Publication date: November 27, 2014
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Publication number: 20140228237
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: January 13, 2014
    Publication date: August 14, 2014
    Applicant: Veracyte, Inc.
    Inventors: Giulia Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8669057
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: March 11, 2014
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8541170
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: September 24, 2013
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Publication number: 20130225662
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: August 17, 2012
    Publication date: August 29, 2013
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Publication number: 20130150257
    Abstract: Compositions and methods are provided to provide an expression signature for a sample, where an alternative splicing index and profile are determined for the sample based on variations in the splicing of messenger RNA for at least one gene in the sample.
    Type: Application
    Filed: December 10, 2012
    Publication date: June 13, 2013
    Applicant: Veracyte, Inc.
    Inventor: Veracyte, Inc.
  • Publication number: 20120220474
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 7, 2010
    Publication date: August 30, 2012
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Publication number: 20110312520
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling for diagnosing disease conditions. In particular, the present invention provides molecular profiles associated with thyroid cancer and other cancers, methods of relating molecular profiles to a diagnosis, and related compositions.
    Type: Application
    Filed: May 11, 2011
    Publication date: December 22, 2011
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Jonathan I. Wilde, James G. Veitch, Bonnie H. Anderson